Company: ERAS
Filing Date: 2025-03-20
Form Type: 10-K
Source: 0000950170-25-042682
Chunk: 321

Company: Erasca, Inc.
Filing Date: 2025-03-20
Form: 10-K
Item: Item 6
Chunk 321
---
 are the same as those described in the summary of significant accounting policies. The CODM assesses performance for the segment based on net loss, which is reported on the consolidated statements of operations and comprehensive loss as consolidated net loss. The measure of segment assets is reported on the consolidated balance sheets as total consolidated assets.

 F-29

 To date, the Company has not generated any product revenue. The Company expects to continue to incur significant expenses and operating losses for the foreseeable future as it advances product candidates through all stages of development and clinical trials and, ultimately, seek regulatory approval. The CODM uses cash forecast models in deciding how to invest into the segment. Such cash forecast models are reviewed to assess the consolidated operating results and performance. Net loss is used to monitor budget versus actual results. Monitoring budgeted versus actual results is used in assessing performance of the segment and in establishing cash forecast models. Significant segment expenses provided to the CODM are the same as presented on the consolidated statements of operations and comprehensive loss as research and development expenses and general and administrative expenses.

Note 18. Subsequent eventsFrom January 1, 2025 through the date of the filing of this Annual Report on Form 10-K, the Company granted options to purchase an aggregate of 14,011,136 shares of its common stock to employees and board members at a weighted-average exercise price of $1.77 per share.

 F-30

Exhibit Index

    ExhibitNumber
     
     Exhibit Description
     
     Incorporated by Reference
     
    Filed Herewith

    Form
     
    Date
     
    Number

    3.1
     
    Amended and Restated Certificate of Incorporation of Erasca, Inc.
     
    8-K
     
    7/20/2021
     
    3.1

    3.2
     
    Amended and Restated Bylaws of Erasca, Inc.
     
    8-K
     
    7/20/2021
     
    3.2

    4.1
     
    Specimen stock certificate evidencing the shares of common stock
     
    S-1
     
    6/25/2021
     
    4.1

    4.2
     
    Amended and Restated Stockholders Agreement, dated April 15, 2020, by and among the Registrant and certain of its stockholders
     
    S-1
     
    6/25/2021
     
    4.2

    4.3